Effect of growth condition on in-vitro susceptibility of Shigella dysenteriae type 1 to killing by murine peritoneal macrophages

Journal of Medical Microbiology

Volumn 44, Issue 2, 1996, Pages 99-104

  Haque, M A ^a   Yoshino, S ^a   Ohki, K ^a   Inada, S ^a   Kohashi, O ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SHIGELLA DYSENTERIAE;

EID: 0029988976     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-44-2-99     Document Type: Article

References (31)

1. Labrec EH, Schneider H, Magnani TJ, Formal SB. Epithelial cell penetration as an essential step in the pathogenesis of bacillary dysentery. J Bacteriol 1964; 88: 1503-1518.
2. Makino S, Sasakawa C, Kamata K, Kurata T, Yoshikawa M. A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell 1986; 46: 551-555.
3. Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun 1986; 51: 461-69.
4. Fontaine A, Arondel J, Sansonetti PJ. Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1. Infect Immun 1988; 56: 3099-3109.
5. Hale TL, Formal SB. Protein synthesis in HeLa or Henle 407 cells infected with Shigella dysenteriae 1, Shigella flexneri 2a, or Salmonella typhimurium W118. Infect Immun 1981; 32: 137-144.
6. Clerc PL, Ryter A, Mounier J, Sansonetti PJ. Plasmid-mediated early killing of eucaryotic cells by Shigella flexneri as studied by infection of J774 macrophages. Infect Immun 1987; 55: 521-527.
7. Qadri F, Haque MA, Hossain A, Azim T, Alam K, Albert MJ. Role of Shigella dysenteriae type 1 slime polysaccharide in resistance to serum killing and phagocytosis. Microb Pathog 1993; 14: 441-449.
8. Qadri F, Haque MA, Hossain A, Albert MJ. Production of slime polysaccharides by Shigella dysenteriae type 1. Microbiol Immunol 1994; 38: 11-18.
9. Gbarah A, Mirelman D, Sansonetti PJ, Verdon R, Bernhard W, Sharon N. Shigella flexneri transformants expressing type 1 (mannose-specific) fimbnae bind to, activate, and are killed by phagocytic cells. Infect Immun 1993; 61: 1687-1693.
10. Mirelman D, Nuchamowitz Y, Izhar M. Interactions between intestinal cells and Shigellae. In: Agabian N, Eisen H (eds) Molecular biology of host-parasite interactions. New York, Alan R. Liss Inc. 1984: 321-330.
11. Qadri F, Haq S, Čižár I. Hemagglutinating properties of Shigella dysenteriae type 1 and other Shigella species. Infect Immun 1989; 57: 2909-2911.
12. Arata S, Newton C, Klein TW, Friedman H. Legionella pneumophila growth restriction in permissive macrophages cocultured with nonpermissive lipopolysaccharide-activated macrophages. Infect Immun 1993; 61: 5056-5061.
13. Gessani S, Testa U, Varano B et al. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. J Immunol 1993; 151: 3758-3766.
14. Alcina A, Fresno M. Activation by synergism between endotoxin and lymphokines of the mouse macrophage cell line J774 against infection by Trypanosoma cruzi. Parasite Immunol 1987; 9: 175-186.
15. Wright SD, Levin SM, Jong MTC, Chad Z, Kabbash LG. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 1989; 169: 175-183.
16. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
17. Nathan C. Interferon-gamma and macrophage activation in cell-mediated immunity. In: Steinman RM, North RJ (eds) Mechanisms of host resistance to infectious agents, tumors, and allografts. New York, Rockefeller University Press. 1986: 165-184.
18. Watanabe H, Nakamura A, Timmis KN. Small virulence plasmid of Shigella dysenteriae 1 strain W30864 encodes a 41,000-dalton protein involved in formation of specific lipopolysaccharide side chains of serotype 1 isolates. Infect Immun 1984; 46: 55-63.
19. Watanabe H, Timmis KN. A small plasmid in Shigella dysenteriae 1 specifies one or more functions essential for O antigen production and bacterial virulence. Infect Immun 1984; 43: 391-396.
20. Qadri F, Hossain SA, Čižár I et al. Congo red binding and salt aggregation as indicators of virulence in Shigella species. J Clin Microbiol 1988; 26: 1343-1348.
21. Sereny B. Experimental Shigella keratoconjunctivitis. A preliminary report. Acta Microbiol Acad Sci Hung 1955; 2: 293-296.
22. Franzon VL, Arondel J, Sansonetti PJ. Contribution of superoxide dismutase and catalase activities to Shigella flexneri pathogenesis. Infect Immun 1990; 58: 529-535.
23. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 1980; 93: 480-489.
24. Murray HW, Cartelli DM. Killing of intracellular Leishmania donovani by human mononuclear phagocytes: evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest 1983; 72: 32-44.
25. Wilson CB, Tsai V, Remington JS. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med 1980; 151: 328-46.
26. Nathan CF. Mechanisms of macrophage antimicrobial activity. Trans R Soc Trop Med Hyg 1983; 77: 620-630.
27. Haider K, Albert MJ, Hossain A, Nahar S. Contact-haemolysm production by entero-invasive Escherichia coli and shigellae. J Med Microbiol 1991; 35: 330-337.
28. Louise CB, Obrig TG. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 1991; 59: 4173-4179.
29. Louise CB, Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 1992; 60: 1536-1543.
30. O'Brien AD, Tesh VL, Donohue-Rolfe A et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiul Immunol 1992; 180: 65-94.
31. Tesh VL, Ramegowda B, Samuel JE. Purified shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 1994; 62: 5085-5094.